Atlas Trials

Immunomodulatory Effects of NB-UVB and Steroids in Vitiligo: A Study on CXCL11 and TEMRA Biomarkers

Clinical trial NCT06946069 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06946069
Sponsor
Assiut University
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
VitiligoNB-UVB
Start date
2025-09-01
Primary completion
2025-12-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.